Biblio Discovery — Demo Discovery Service

7 hasil untuk "Carrell, Samuel"

Menampilkan 1–7 · 1,13 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Nox4 NADPH oxidase contributes to smooth muscle cell phenotypes associated with unstable atherosclerotic plaques

    Xu, Shaoping; Chamseddine, Ali H.; Carrell, Samuel dkk.

    Redox Biol · 2014 · Inggris · PubMed Central

    Plaque instability associated with acute coronary syndromes results in part from apoptosis and senescence of cells within the atherosclerotic (AS) lesion. Increased cellular oxidative stress has been proposed to contribute to plaque progression and changes in composition, leading to plaque…

  2. Artikel Jurnal Teks lengkap

    Co‐Opting MBNL‐Dependent Alternative Splicing Cassette Exons to Control Gene Therapy in Myotonic Dystrophy

    Carrell, Samuel T.; Carrell, Ellie M.; Giovenco, Ryan dkk.

    Ann Neurol · 2025 · Inggris · PubMed Central

    OBJECTIVE: Myotonic dystrophy type 1 (DM1) is a highly variable, multisystemic genetic disorder caused by a CTG repeat expansion in the 3′ untranslated region of DMPK. Toxicity is exerted by repeat‐containing DMPK transcripts that sequester muscleblind‐like (MBNL) proteins and lead to deleterious…

  3. Artikel Jurnal Teks lengkap

    Detection of expanded RNA repeats using thermostable group II intron reverse transcriptase

    Carrell, Samuel T; Tang, Zhenzhi; Mohr, Sabine dkk.

    Nucleic Acids Res · 2017 · Inggris · PubMed Central

    Cellular accumulation of repetitive RNA occurs in several dominantly-inherited genetic disorders. Expanded CUG, CCUG or GGGGCC repeats are expressed in myotonic dystrophy type 1 (DM1), myotonic dystrophy type 2 (DM2), or familial amyotrophic lateral sclerosis, respectively. Expanded repeat RNAs…

  4. Artikel Jurnal Teks lengkap

    Role for Nox1 NADPH Oxidase in Atherosclerosis

    Sheehan, Andrea L.; Carrell, Samuel; Johnson, Bryon dkk.

    Atherosclerosis · 2011 · Inggris · PubMed Central

    OBJECTIVE: Examine the contribution of Nox1 NADPH oxidase to atherogenesis. METHODS AND RESULTS: Male apolipoprotein E deficient mice (ApoE(−/−)) and male mice deficient in both apolipoprotein E and Nox1 (ApoE(−/−) Nox1(−/y)) received an atherogenic diet for 18 weeks. Mean blood pressures, body…

  5. Artikel Jurnal Teks lengkap

    Dmpk gene deletion or antisense knockdown does not compromise cardiac or skeletal muscle function in mice

    Carrell, Samuel T.; Carrell, Ellie M.; Auerbach, David dkk.

    Hum Mol Genet · 2016 · Inggris · PubMed Central

    Myotonic dystrophy type 1 (DM1) is a genetic disorder in which dominant-active DM protein kinase (DMPK) transcripts accumulate in nuclear foci, leading to abnormal regulation of RNA processing. A leading approach to treat DM1 uses DMPK-targeting antisense oligonucleotides (ASOs) to reduce levels of…

  6. Artikel Jurnal Teks lengkap

    Reducing levels of toxic RNA with small molecules

    Coonrod, Leslie A.; Nakamori, Masayuki; Wang, Wenli dkk.

    ACS Chem Biol · 2013 · Inggris · PubMed Central

    Myotonic dystrophy (DM) is one of the most common forms of muscular dystrophy. DM is an autosomal dominant disease caused by a toxic gain of function RNA. The toxic RNA is produced from expanded non-coding CTG/CCTG repeats, and these CUG/CCUG repeats sequester the Muscleblind-like (MBNL) family of…

  7. Artikel Jurnal Teks lengkap

    Toward Trial Readiness in Congenital Myotonic Dystrophy

    Kiefer, Michael; Hartman, Julia M.; Berggren, Kiera N. dkk.

    Neurol Genet · 2026 · Inggris · PubMed Central

    BACKGROUND AND OBJECTIVES: Congenital myotonic dystrophy (CDM) is a life-limiting genetic disorder present at birth, marked by profound motor and cognitive impairments. CDM is the most severe form of myotonic dystrophy type 1 (DM1), both caused by a cytosine–thymine–guanine (CTG) repeat expansion…